BRIEF-Repros Says Received EMA Feedback That Negative Opinion Is Likely To Be Received In Jan 2018

* REPROS THERAPEUTICS INC.® RECEIVES FEEDBACK FOLLOWING AN ORAL EXPLANATION WITH THE EUROPEAN MEDICINES AGENCY
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.